Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Urology Research Center
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|